Minneapolis-based Allina Health reported an operating loss of $16.6 million (-0.3% margin) for the year ended Dec. 31, 2024, marking a $344 million turnaround from the $360.5 million loss (-7% margin) reported in 2023, according to recently published financial documents.
Four things to know:
1. Total revenue increased 12.3% year over year to $5.8 billion while expenses grew by 4.8% to $5.8 billion in 2024
2. Volume growth contributed to revenue gains, particularly in outpatient and surgical services, according to the health system. Allina also benefited from operational efficiency initiatives and cost-reduction efforts.
3. After accounting for nonoperating items, such as investment returns, Allina reported a net income of $163.8 million in 2024, compared to a net loss of $163.9 million in 2023.
4. Cash and cash equivalents was $227.1 million as of Dec. 31, 2024. Long-term debt stood at $1.7 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
